Literature DB >> 10918061

A structure-function analysis of serine/threonine phosphorylation of the thrombopoietin receptor, c-Mpl.

Y Miyakawa1, J G Drachman, B Gallis, A Kaushansky, K Kaushansky.   

Abstract

Thrombopoietin (TPO), the critical regulator of platelet production, acts by binding to its cell surface receptor, c-Mpl. Numerous studies have shown that TPO binding leads to JAK2 kinase activation and Tyr phosphorylation of c-Mpl and several intracellular signaling intermediates, events vital for the biological activity of the hormone. In contrast, virtually nothing is known of the role of Ser or Thr phosphorylation of c-Mpl. By using phosphoamino acid analysis we found that Ser residues of c-Mpl were constitutively phosphorylated in receptor-bearing cells, levels that were increased following exposure of cells to TPO. To identify which residues were modified, and to determine the functional consequences of their phosphorylation, we generated a series of Ser to Ala mutations of a truncated c-Mpl receptor (T69) capable of supporting TPO-induced cell growth. Of the eight Ser within T69 we found that at least four are phosphorylated in TPO-stimulated cells. The mutation of each of these residues alone had minimal effects on TPO-induced proliferation, but substitution of all of the phosphoserine residues with Ala reduced the capacity of the receptor to support cell growth by over 50%. Additionally, the Ser at cytoplasmic position 18 is not detectably phosphorylated. However, the mutation of Ser-18 to Ala nearly abrogates TPO-induced proliferation and co-precipitation of JAK2 with Mpl. This study provides the first systematic analysis of the role of Ser residues in c-Mpl signaling.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10918061     DOI: 10.1074/jbc.M005080200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  5 in total

1.  Phosphorylation of podocalyxin (Ser415) Prevents RhoA and ezrin activation and disrupts its interaction with the actin cytoskeleton.

Authors:  Hirotaka Fukasawa; Hiroaki Obayashi; Sandra Schmieder; Jaesung Lee; Pradipta Ghosh; Marilyn G Farquhar
Journal:  Am J Pathol       Date:  2011-09-25       Impact factor: 4.307

Review 2.  New Insights Into the Differentiation of Megakaryocytes From Hematopoietic Progenitors.

Authors:  Leila J Noetzli; Shauna L French; Kellie R Machlus
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-05-02       Impact factor: 8.311

Review 3.  Structural and functional hot spots in cytokine receptors.

Authors:  C J Bagley; J M Woodcock; M A Guthridge; F C Stomski; A F Lopez
Journal:  Int J Hematol       Date:  2001-04       Impact factor: 2.490

4.  Targeting c-Mpl for revival of human immunodeficiency virus type 1-induced hematopoietic inhibition when CD34+ progenitor cells are re-engrafted into a fresh stromal microenvironment in vivo.

Authors:  Prasad S Koka; Christina M R Kitchen; Srinivasa T Reddy
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

5.  New advances in the treatment of adult chronic immune thrombocytopenic purpura: role of thrombopoietin receptor-stimulating agents.

Authors:  Ara Metjian; Charles S Abrams
Journal:  Biologics       Date:  2009-12-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.